Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar 22:4:10.
doi: 10.1186/1756-8722-4-10.

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Gerhard J Molderings  1 , Stefan Brettner, Jürgen Homann, Lawrence B Afrin
Affiliations
Review

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Gerhard J Molderings et al. J Hematol Oncol. .

Abstract

Mast cell activation disease comprises disorders characterized by accumulation of genetically altered mast cells and/or abnormal release of these cells' mediators, affecting functions in potentially every organ system, often without causing abnormalities in routine laboratory or radiologic testing. In most cases of mast cell activation disease, diagnosis is possible by relatively non-invasive investigation. Effective therapy often consists simply of antihistamines and mast cell membrane-stabilising compounds supplemented with medications targeted at specific symptoms and complications. Mast cell activation disease is now appreciated to likely be considerably prevalent and thus should be considered routinely in the differential diagnosis of patients with chronic multisystem polymorbidity or patients in whom a definitively diagnosed major illness does not well account for the entirety of the patient's presentation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagnostic algorithm.
See this image and copyright information in PMC

References

    1. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603–625. doi: 10.1016/S0145-2126(01)00038-8. - DOI - PubMed
    1. Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007;37:435–453. doi: 10.1111/j.1365-2362.2007.01807.x. - DOI - PubMed
    1. Homann J, Kolck UW, Ehnes A, Frieling T, Raithel M, Molderings GJ. Systemic mastocytosis - definition of an internal disease. Med Klin (Munich) 2010;105:544–553. doi: 10.1007/s00063-010-1093-8. - DOI - PubMed
    1. Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: Proposed diagnostic criteria. J Allergy Clin Immunol. 2010;126:1099–1104. doi: 10.1016/j.jaci.2010.08.035. - DOI - PMC - PubMed
    1. Hamilton MJ, Castells M, Greenberger NJ. Mast cell activation syndrome - a newly recognized cause of recurrent acute abdominal pain. Gastroenterology. 2010;138(Suppl 1):S89.

Publication types

Substances